Plasma biomarkers of brain atrophy in Alzheimer's disease
about
Blood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyBiomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomicsImago Mundi, Imago AD, Imago ADNIFunctional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots.A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease miceTheHiveDB image data management and analysis framework.Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.Cognitive Variability during Middle-Age: Possible Association with Neurodegeneration and Cognitive ReserveThe future of blood-based biomarkers for Alzheimer's disease.Developing novel blood-based biomarkers for Alzheimer's diseasePlasma based markers of [11C] PiB-PET brain amyloid burden.Plasma proteins predict conversion to dementia from prodromal diseaseCirculating miRNA biomarkers for Alzheimer's diseaseUpregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.Plasma proteomics for the identification of Alzheimer disease.Blood protein predictors of brain amyloid for enrichment in clinical trials?Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interactionEffects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults.The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.Fibrinogen and altered hemostasis in Alzheimer's diseasePlasma biomarkers for Alzheimer's disease: much needed but tough to find.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.New insight into neurodegeneration: the role of proteomics.Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.Reduction of Cerebral and Corpus Callosum Volumes in Childhood-Onset Systemic Lupus Erythematosus: A Volumetric Magnetic Resonance Imaging Analysis.Fibrin deposited in the Alzheimer's disease brain promotes neuronal degenerationSoluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead.Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.Complement in the pathogenesis of Alzheimer's disease.Blood will out: vascular contributions to Alzheimer's disease.Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease.Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol."Immune Gate" of Psychopathology-The Role of Gut Derived Immune Activation in Major Psychiatric Disorders.Detection of Alzheimer's Disease
P2860
Q26774743-3C83824B-826E-4B0A-AEE6-1221BC23B584Q27024518-158DC652-C30B-4401-810C-958F56954214Q28650395-F4D94C1D-902F-41D4-A967-FDC8CFD987EFQ30352067-0C5F415E-2369-4D8D-8E5C-6E73A6243708Q30579707-9787B725-B07E-4E11-B3FB-20B37FEF1978Q30734877-8884E4B3-F606-4A55-BAC1-27C2CF6073CAQ33652456-1BA8290C-C325-4126-A0F8-07BF1127E468Q33745920-B73DD441-ECB3-420E-B9FB-5B721601D04EQ33780670-C0ED8544-905B-46D8-90B8-FB4A92400191Q34026317-62953BEA-0F22-4D6B-9654-DA38D7A5716BQ34394080-2E5FCC37-DA6E-4F6F-9477-7609AA1F8C8CQ34427001-1451217A-5C66-4C18-BD44-8092FA76580EQ34556953-88217C80-88AC-485C-8995-B14E820C2E57Q34904013-C4787968-65AE-419E-AE4E-0B317B18507BQ35191570-2594B4F5-CA7F-48B0-88E7-8F63E60036D4Q36256076-EAA0F0EC-3808-4C07-89D4-0C2A0696A2EDQ36767124-07AD08CD-A287-4E29-9CBD-1E1E46FC1FFDQ36926754-B992C977-38CB-4AE9-B3A8-A79B6DC2CB21Q37104293-7EDBF45F-65D1-4D8E-A979-96F0C7282505Q37395886-84BAD442-668A-41CB-B4C3-D45A5CC0FC64Q37656221-20B1B81B-0234-4F67-80D3-F565DB5849C9Q38032520-FDFDC770-4C4A-4670-9B65-E886EC0C6E40Q38037157-81EA399D-1C65-4D84-8CDF-84C753905013Q38060574-20191966-04AB-480E-BDDF-75EAE8D387F1Q38170010-32658D31-B17A-4242-BB6F-0C3AC53397DFQ39447009-3109CD45-5C19-4308-83E5-B7CCD7FA4076Q40426419-88F413A4-C458-4EDC-82B1-97CBAA9114ABQ40845375-BF4E6822-C706-433A-B04B-BAC76C9110D6Q41916686-D237B62B-B56B-4A05-9D6A-CC92D15F3742Q43244936-453F87B6-1DC0-4A6B-975E-6C9B70EB5D90Q47201004-C5E84DB1-B97F-4320-B33A-768793EF952CQ47709505-13B5CE32-85D3-430D-9F45-A4475B9B1F49Q49498166-1F67CA8B-9744-40B4-8E47-FD1FD922761BQ50221800-5786C46A-EFCD-4FCF-A8DC-CE33CA8BE19FQ51760901-2E6AD2AE-ECF3-4513-89CD-67EE952327E7Q53345656-E3FD631F-7B63-4F52-A7DF-41E5D2DF619DQ53447021-A27023D5-86FB-40BB-AFF6-0149AD2D7F90Q55110638-994E26C7-786A-4854-AFBA-6634E00A4417Q58706105-63B25E2F-F44D-4903-B018-62048ADE5754
P2860
Plasma biomarkers of brain atrophy in Alzheimer's disease
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Plasma biomarkers of brain atrophy in Alzheimer's disease
@ast
Plasma biomarkers of brain atrophy in Alzheimer's disease
@en
Plasma biomarkers of brain atrophy in Alzheimer's disease
@nl
type
label
Plasma biomarkers of brain atrophy in Alzheimer's disease
@ast
Plasma biomarkers of brain atrophy in Alzheimer's disease
@en
Plasma biomarkers of brain atrophy in Alzheimer's disease
@nl
prefLabel
Plasma biomarkers of brain atrophy in Alzheimer's disease
@ast
Plasma biomarkers of brain atrophy in Alzheimer's disease
@en
Plasma biomarkers of brain atrophy in Alzheimer's disease
@nl
P2093
P2860
P50
P921
P1433
P1476
Plasma biomarkers of brain atrophy in Alzheimer's disease
@en
P2093
Andrew Simmons
Christian Spenger
Mirsada Causevic
P2860
P304
P356
10.1371/JOURNAL.PONE.0028527
P407
P50
P577
2011-01-01T00:00:00Z